Latest News from HNF
Stay up to date with our most recent news and updates on CMT and INs.
CMT1A Clinical Trial Update: Pharnext PREMIER trial of PXT3003
CMT1A Clinical Trial Update: Pharnext PREMIER trial of PXT3003 The PREMIER Trial, which is being conducted in patients with mild-to-moderate CMT1A, is expected to enroll approximately 350 subjects ages 16-65 with a confirmed genetic diagnosis of CMT1A....
Faces of CMT Photography Contest
HNF Launches NEW Virtual CMT Fitness Platform with Ambassador Instructors
The Hereditary Neuropathy Foundation believes that activity plays an essential role in physical and mental well being, especially for people affected by debilitating diseases like Charcot-Marie-Tooth. The Movement is Medicine™ mission is to promote the safe adoption...
Mouse Models of Human CNTNAP1 Mutations: Strategies to Rescue and Restore Functions
MANZOOR A. BHAT, M.S., PH.D., DEPARTMENT OF CELLULAR AND INTEGRATIVE PHYSIOLOGY UT HEALTH SAN ANTONIO, TX Myelination of nerves has the sole purpose of allowing axons to propagate nerve impulses over long distances in a saltatory manner. Peripheral or central...
Act of Kindness: From Strangers to Instant Friends
On October 14, 2020, Winter School athletes in Wisconsin hit the Tuscobia Trail to raise much needed funding for HNF’s gene therapy program in support of Alana Kohler. This amazing school reached out to HNF after they saw a media piece on Alana Kohler who has GDAP1...
Free CMT Genetic Testing for a Common Axonal type of CMT to Prepare for Clinical Trial
A new type of Charcot-Marie-Tooth (CMT) has recently been identified caused by mutations in the SORD gene. This is likely the most common recessive type of CMT; and the best part is that drugs are likely available that have been developed, in principle, for diabetic...